Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
Tracking the tropics: Tropical wave likely to develop in eastern Gulf of Mexico, National Hurricane Center says
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Goodrx Holdings Inc Cl A
(NQ:
GDRX
)
9.050
+0.170 (+1.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Goodrx Holdings Inc Cl A
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Shares of GoodRx Holdings Fell 18.7% Lower This Week
November 18, 2022
The company, which focuses on delivering prescription drug discounts, has struggled this year.
Via
The Motley Fool
2 Growth Stocks Down More Than 50% From Their Highs That Could Be Hot Buys for 2023
November 16, 2022
These businesses could perform much better next year.
Via
The Motley Fool
Can Doximity Stock Keep On Climbing?
November 15, 2022
A positive earnings report recently pushed Doximity through the roof, but Investors want to know whether the stock can deliver long-term gains.
Via
The Motley Fool
Robinhood, MicroStrategy And Other Big Losers From Wednesday
November 10, 2022
U.S. stocks closed lower on Wednesday, with the Dow Jones dipping more than 600 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why GoodRx Stock Was Plunging Today
November 09, 2022
Revenue continued to slide at the healthcare company.
Via
The Motley Fool
GoodRx Holdings, Inc. (GDRX) Q3 2022 Earnings Call Transcript
November 08, 2022
GDRX earnings call for the period ending September 30, 2022.
Via
The Motley Fool
10 Analysts Have This to Say About GoodRx Holdings
November 04, 2022
Within the last quarter, GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings:
Via
Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
Gainers
Via
Benzinga
Expert Ratings for GoodRx Holdings
October 11, 2022
GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
November 10, 2022
Gainers
Via
Benzinga
What 13 Analyst Ratings Have To Say About GoodRx Holdings
August 09, 2022
GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
November 09, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 09, 2022
Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings...
Via
Benzinga
Where GoodRx Holdings Stands With Analysts
November 04, 2022
Over the past 3 months, 10 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Should You Buy the Nasdaq's 4 Worst-Performing Stocks of 2022?
October 16, 2022
These four tech stocks are down nearly 90%.
Via
The Motley Fool
Before Pushing Others At Work, Take A Look In The Mirror
October 14, 2022
Leaders often see their job as driving greatness from others. But the first step is developing your own leadership style.
Via
Investor's Business Daily
Alphabet To $134? Plus This Analyst Slashes Price Target On McDonald's
October 11, 2022
Credit Suisse cut the price target on Alphabet Inc. (NASDAQ: GOOGL) from $140 to $134. Credit Suisse analyst Stephen Ju maintained an Outperform rating on the stock. Alphabet shares fell 1.2% to $96.69...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
November 04, 2022
Upgrades
Via
Benzinga
Where GoodRx Holdings Stands With Analysts
October 11, 2022
Over the past 3 months, 11 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
September 16, 2022
Via
Benzinga
What 14 Analyst Ratings Have To Say About GoodRx Holdings
September 07, 2022
Over the past 3 months, 14 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Upgrades
Via
Benzinga
Looking Into GoodRx Holdings's Return On Capital Employed
August 29, 2022
GoodRx Holdings (NASDAQ:GDRX) brought in sales totaling $191.80 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 111.51%, resulting in a loss of $1.42 million.
Via
Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
August 18, 2022
Gainers
Via
Benzinga
The Most Expensive Drug From Novartis Associated With Two Deaths: Report
August 12, 2022
Two children with spinal muscular atrophy have died after receiving Novartis AG's (NYSE: NVS) Zolgensma, a one-time gene therapy, spotlighting its risks and questioning the safety of genetic medicines...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
August 12, 2022
Via
Benzinga
WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday
August 10, 2022
OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
Via
Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....
Via
Benzinga
Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday
August 09, 2022
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 09, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.